Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Metabasis Therapeutics, Inc (NASDAQ: MBRX)
Sector: Medical
Current Price :
$0.31
52 Week Low
$0.23
52 Week High
$0.91
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
35M
Market Cap:
$0.02B
Avg Volume:
141403
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
15 Breakout Stocks On Huge Volume
Oct 08, 2009 09:51 AM |
AVNR
,
BRCD
,
CGR
,
ENZN
,
GIII
,
ICTG
Earnings Review: March 30, 2009
Mar 30, 2009 07:35 PM |
MBRX
,
OXM
,
TORM
Analyst Comments: AtheroGenics, Toyota, Jamba, GlaxoSmithKline, Metabasis, AFLAC, Crown Castle, Epicor, Amylin Pharma, CNOOC, Skyworks, Tejon
Oct 02, 2008 08:33 AM |
AFL
,
AGIX
,
AMLN
,
BBI
,
CAS
,
CCI
Analyst Comments: Alexza Pharma, Abbott Lab, Metabasis, Quicksilver, ASM International
Jun 13, 2008 04:45 PM |
ABT
,
ALXA
,
AMAT
,
ASMI
,
KWK
,
MBRX
Analyst Comments: deCODE, BorgWarner, Pride International, ChoicePoint, Metabasis Therapeutics, Owens Illinois, Cummins
May 02, 2008 02:42 PM |
BWA
,
CMI
,
CPS
,
DCGN
,
MBRX
,
OI
More Articles on MBRX..
Market News
More News on MBRX..
Press Releases
More Press Releases on MBRX..
SEC Filings
More SEC Filings on MBRX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
MBRX
Compare to S&P
YTD
21.82 %
24.42 %
4 Weeks
9.07 %
12.54 %
12 Weeks
20.23 %
14.11 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-11.11 %
EPS Growth in Last Year:
128.57 %
Sales Growth in Last Quarter:
-49.72 %
Sales Growth in Last Quarter:
248.29 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##